Clinical Trial Update: Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update of abiraterone acetate in relapsed/metastatic salivary gland cancers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Salivary Glands Tumors | Phase 2 | Status: COMPLETED